TIFAC releases report on status, issues, technology readiness and challenges in API production
It was released along with a white paper on ‘Focused Interventions for ‘Make in India’: Post COVID 19’ which brought out the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
APIs
Delay in customs clearance of China consignments may hamper pharma production: Industry
To avoid disruption in medicines production, the industry seeks immediate intervention from the government
Bulk drug manufacturers seek support from govt, regulatory authorities
Suggest fast track regulatory clearance/approval, loan term extension etc.
Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy
Companies investing in backward integration, new age technology, etc. would get the preference in the PLI scheme
Pharma MSMEs ask government to extend incentives of PLI scheme
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits
‘Essential’ pharmaceuticals amid disrupted supply chains- A legal nightmare!
Can COVID-19 and the lockdown qualify as a force majeure event even when the pharmaceutical industry was never under a lockdown?…
COVID-19 restricts Indian pharma export growth to 7.6 per cent in FY’20
India exported pharma products to 202 destinations in FY’20
IICT, LAXAI LifeSciences collaborate for key pharma intermediates
The collaboration will primarily focus on umifenovir, remdesivir and a key intermediate of hydroxychloroquine
Restrategising to survive and thrive
Anwar Daud, Managing Director, ZIM Laboratories gives an overview of some measures that the government and the industry needs to…
Will the industry sell COVID-19 meds at the min production costs?
Will the pharma industry come through? Can the pharma industry resist pressures from investors and shareholders and sacrifice…